Patent details
EP2367542
Title:
ORAL DOSAGE FORMS OF BENDAMUSTINE.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP2367542
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09796303.7
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:
Dates
Filing date:
03/12/2009
Grant date:
01/01/2014
EP Publication Date:
01/01/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
01/01/2014
EP B1 Publication Date:
01/01/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
02/12/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
02/02/2023
Name:
PHARMA& SCHWEIZ GMBH
Address:
Riedstrasse 1, 6330, Cham, Switzerland (CH)
Historical Applicant/holder
From:
02/02/2023
To:
02/02/2023
Name:
Astellas Deutschland GmbH
Address:
Ridlerstraße 57, 80339, München, Germany (DE)
From:
01/01/2014
To:
02/02/2023
Name:
Astellas Deutschland GmbH
Address:
Georg-Brauchle-Ring 64-66, 80992 MÜNCHEN, Germany (DE)
Agent
Name:
drs. O. Griebling
From:
01/01/2014
Address:
p/a Octrooibureau Griebling B.V.
Sportweg 10, 5037 AC, Tilburg, Netherlands (NL)
To:
Inventor
1
Name:
COLLEDGE, Jeffrey
Address:
2300 AH, LEIDEN, Netherlands (NL)
2
Name:
OLTHOFF, Margaretha
Address:
2300 AH, LEIDEN, Netherlands (NL)
Priority
Priority Patent Number:
08075915
Priority Date:
03/12/2008
Priority Country:
European Patent Office (EPO) (EP)
Classification
Main IPC Class:
A61K 9/48 ;
IPC or IDT classification:
A61K 9/14 ;
A61K 31/4184 ;
Publication
Bulletin
1
Bulletin Heading:
CO
Journal edition number:
07/23
Publication date:
15/02/2023
Description:
Changes in the Netherlands Patent Register
2
Bulletin Heading:
EP3
Journal edition number:
2014/15
Publication date:
09/04/2014
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
Bulletin Heading:
EP2
Journal edition number:
2014/02
Publication date:
08/01/2014
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
201401
Publication date:
01/01/2014
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202300280B
Date Registered:
02/02/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
drs. O. Griebling
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
PHARMA& SCHWEIZ GMBH
Address:
Riedstrasse 1, 6330, Cham, Switzerland (CH)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of Address
Change Kind/ Decision Type:
Owner
Deed Number:
RC202300280A
Date Registered:
02/02/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
drs. O. Griebling
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
31/12/2025
Grace Period End Date:
30/06/2026
Annual Fee Number:
17
Annual Fee Amount:
1100 Euro
Penalty Fee Amount:
550 Euro
Last Annual Payment Date:
19/12/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
1000 Euro
Payer:
Dennemeyer and Co
Filing date
Document type
Document Description
Number of pages
File Type
02/04/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/0/3/6/9/0509796303/docs/ep09796303.7_2_outgoingcorrespondence20140402.pdf
01/04/2014
Outgoing Correspondence
Outgoing Letter
2
PDF
/3/0/3/6/9/0509796303/docs/ep09796303.7_0_outgoingcorrespondence20140401.pdf
01/04/2014
Claims
Translated claims
2
PDF
/3/0/3/6/9/0509796303/docs/ep09796303.7_1_claims20140401.pdf
01/04/2014
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/3/0/3/6/9/0509796303/docs/ep09796303.7_3_incomingcorrespondencepaper20140401.pdf
28/03/2014
Claims
Translated claims
2
PDF
/3/0/3/6/9/0509796303/docs/ep09796303.7_5_claims20140328.pdf
26/02/2014
Incoming Correspondence Paper
Correspondence address details
1
PDF
/3/0/3/6/9/0509796303/docs/ep09796303.7_4_incomingcorrespondencepaper20140226.pdf